LISATA THERAPEUTICS, INC. — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8b5a8a96-9a41-428c-a61a-24d24927f852/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-18.2M | 2025-01-01 – 2025-12-31 | evidence 0000320017-26-000023 |
| FY 2024 | $-22.4M | 2024-01-01 – 2024-12-31 | evidence 0000320017-25-000011 |
| FY 2023 | $-25.7M | 2023-01-01 – 2023-12-31 | evidence 0000320017-24-000007 |
| FY 2022 | $-57.6M | 2022-01-01 – 2022-12-31 | evidence 0000320017-23-000011 |
| FY 2021 | $-29.1M | 2021-01-01 – 2021-12-31 | evidence 0000320017-22-000016 |
| FY 2020 | $-19.1M | 2020-01-01 – 2020-12-31 | evidence 0000320017-21-000043 |
| FY 2019 | $-20.1M | 2019-01-01 – 2019-12-31 | evidence 0000320017-20-000016 |
| FY 2018 | $-17.0M | 2018-01-01 – 2018-12-31 | evidence 0000320017-19-000024 |
| FY 2017 | $-27.6M | 2017-01-01 – 2017-12-31 | evidence 0000320017-19-000024 |
| FY 2016 | $-29.5M | 2016-01-01 – 2016-12-31 | evidence 0000320017-18-000021 |
| FY 2015 | $-113.8M | 2015-01-01 – 2015-12-31 | evidence 0000320017-16-000098 |
| FY 2014 | $-57.7M | 2014-01-01 – 2014-12-31 | evidence 0000320017-15-000013 |
| FY 2013 | $-36.8M | 2013-01-01 – 2013-12-31 | evidence 0000320017-14-000007 |
| FY 2012 | $-30.4M | 2012-01-01 – 2012-12-31 | evidence 0000320017-13-000009 |
| FY 2011 | $-34.0M | 2011-01-01 – 2011-12-31 | evidence 0001445305-12-002656 |
| FY 2010 | $-25.9M | 2010-01-01 – 2010-12-31 | evidence 0001445305-12-002656 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
LISATA THERAPEUTICS, INC. — all facts · Revenue · Net Income